Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
311 INR | -0.35% | -2.90% | -21.31% |
May. 22 | Indoco Remedies Gets Final Nod from US FDA for Pregabalin Capsules | MT |
May. 16 | Indoco Remedies Gets Zero Observations from US FDA for Navi Mumbai, India Plant, IAS Division | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.31% | 345M | |
+38.69% | 728B | |
+33.91% | 603B | |
-4.49% | 360B | |
+20.24% | 332B | |
+2.12% | 279B | |
+15.83% | 244B | |
+7.71% | 207B | |
-5.60% | 205B | |
-0.35% | 163B |
- Stock Market
- Equities
- INDOCO Stock
- News Indoco Remedies Limited
- Transcript : Indoco Remedies Limited, Q2 2023 Earnings Call, Nov 11, 2022